Header Logo

Connection

Ross Abrams to Recombinant Proteins

Back to Details
This is a "connection" page, showing publications Ross Abrams has written about Recombinant Proteins.
Ross Abrams
Connection Strength
0.023
Recombinant Proteins
  1. Multicenter phase II trial of adjuvant therapy for resected pancreatic cancer using cisplatin, 5-fluorouracil, and interferon-alfa-2b-based chemoradiation: ACOSOG Trial Z05031. Ann Oncol. 2011 Feb; 22(2):348-54.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.